Pharmaceutical preparations and substances for the treatment of metabolic disorders and disorders which are a result of one or more mutations within the lipoprotein lipase gene; gene therapy vectors; biological preparations for medical use; biological preparations for medical use, namely, metabolic disorders and disorders which are a result of one or more mutations within the lipoprotein lipase gene; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, ...

Biological preparations for medical use in medical and clinical gene therapy and cell therapy; clinical medical reagents for use in gene therapy, gene diagnosis, and gene testing; pharmaceutical preparations, namely, vaccines for use in gene therapy; gene therapy and prophylaxis products, namely, gene-based biological preparations and medical reagents for use in gene regulation and gene modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, bloo...